Please login to the form below

Not currently logged in
Email:
Password:

Thomas Dittrich takes up CFO role at Shire

He also joins the Irish biotech’s board

SThomas Dittrichhire appoints Thomas Dittrich as its new chief financial officer and simultaneously he becomes an executive member of the board of directors and a member of the executive committee.

He said: “I look forward to working with the board, the executive committee and the finance organisation as we build upon Shire’s strong fundamentals to drive future growth and shareholder value.”

Prior to joining Shire, Dittrich served as chief financial officer at Sulzer, an industrial engineering and manufacturing company and before this, he was at Amgen as its vice president, finance corporate planning and chief accounting officer.

Susan Kilsby, chairman of the board, Shire, said: “Thomas is a talented global executive who will bring to Shire a broad range of experience from both inside and outside the pharmaceutical industry.

“The board and I look forward to working with him during this transformational time in the company’s history.”

27th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics